共 50 条
- [1] PALLAS: PAlbociclib Collaborative Adjuvant Study: A randomized phase 3 trial of palbociclib with adjuvant endocrine therapy versus endocrine therapy alone for HR+/HER2-early breast cancerCANCER RESEARCH, 2016, 76Mayer, E.DeMichele, A.Dubsky, P.Barry, W.Metzger, O.Symmans, W. F.Burstein, H.Miller, K.Wolff, A.Rastogi, P.Loibl, S.von Minckwitz, G.Goulioti, T.Zardavas, D.Fesl, C.Koehler, M.Bartlett, C. HuangChen, L.Piccart, M.Winer, E.Gnant, M.
- [2] PALLAS: PALbociclib CoLlaborative Adjuvant Study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for HR+/HER2-early breast cancerCANCER RESEARCH, 2018, 78 (04)Mayer, EricaDeMichele, AngelaGnant, MichaelBarry, WilliamPfeiler, GeorgMetzger, OttoBurstein, HaroldMiller, KathyRastogi, PriyaLoibl, SibylleGoulioti, TheodoraZardavas, DimitriosFesl, ChristianKoehler, MariaHuang-Bartlett, CynthiaHuang, XinPiccart, MartineWiner, EricWolff, Antonio
- [3] Treatment exposure and discontinuation in the PALLAS trial: PALbociclib CoLlaborative Adjuvant Study of palbociclib with adjuvant endocrine therapy for HR+/HER2-early breast cancerCANCER RESEARCH, 2021, 81 (04)Mayer, Erica L.Fesl, ChristianDueck, AmylouGnant, MichaelDeMichele, Angela
- [4] PALLAS: PALbociclib CoLlaborative adjuvant study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone HR1/HER2-early breast cancerANNALS OF ONCOLOGY, 2017, 28Mayer, E. L.Demichele, A. M.Pfeiler, G.Barry, W.Metzger, O.Rastogi, P.Symmans, F.Burstein, H. J.Miller, K.Loibl, S.Schmatloch, S.Goulioti, T.Zardavas, D.Fesl, C.Koehler, M.Bartlett, C. HuangHuang, X.Piccart, M.Winer, E.Gnant, M.
- [5] Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancerBREAST CANCER RESEARCH AND TREATMENT, 2025, : 385 - 397Shinn, EileenZahrieh, DavidDemichele, AngelaZdenkowski, NickLemieux, JulieMao, JunBjelic-Radisic, VesnaNaughton, Michelle J.Pfeiler, GeorgGelmon, KarenBalko, Justin M.Egle, DanielZoppoli, GabrieleTraina, TiffanyJimenez, Miguel MartinNovoa, Silvia AntolinHaddad, TufiaChan, ArleneRing, AlistairWolff, AntonioSymmans, William FraserPonce Lorenzo, JoseSabanathan, DhanushaBurstein, Hal J.Nowecki, Zbigniew IreneuszPristauz-Telsnigg, GundaBrufsky, AdamBellet-Ezquerra, MeritxellFoukakis, TheodorosNovik, YelenaRubovszky, GaborSinger, Christian F.Muehlbacher, KarolineFilho, Otto MetzgerGoulioti, TheodoraLaw, ErnestPartridge, Ann H.Carey, Lisa A.Zoroufy, AlexHlauschek, DominikFesl, ChristianMayer, Erica L.Gnant, Michael
- [6] PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2-early breast cancerANNALS OF ONCOLOGY, 2020, 31 : S1145 - S1145Mayer, E. L.Gnant, M. I.DeMichele, A.Martin, M.Burstein, H.Prat, A.Rubovszky, G.Miller, K. D.Pfeiler, G.Winer, E. P.Zdenkowski, N.Anderson, D.Nowecki, Z.Loibl, S.Fohler, H.Metzger, O.Fumagalli, D.Theall, K. PuyanaFesl, C.Dueck, A.
- [7] Quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05)CANCER RESEARCH, 2022, 82 (04)Naughton, Michelle JoyZahrieh, DavidGnant, MichaelZdenkowski, NicholasLemieux, JulieMao, Jun J.Bjelic-Radisic, VesnaShinn, EileenBalic, MarijaThomssen, ChristophNeisel, JaneRuiz-Echarri, ManuelLoibl, SibylleIsaacs, ClaudineCameron, DavidCarrasco, Fernando Manuel HenaoGoetz, MatthewWette, ViktorWerutsky, GustavoRugo, HopeVetter, MarcusTseng, Ling-MingMiller, KathyFitzal, FlorianGil, Juan Miguel GilPark, HaeseongLinderholm, BarbroBajetta, EmilioDayao, ZoneddyPrat, AleixEhrhardt, KarinMetzger, OttoArahmani, AmalLaw, ErnestPartridge, AnnCarey, LisaZoroufy, AlexDueck, AmylouHlauschek, DominikDeMichele, AngelaMayer, Erica
- [8] Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS TrialJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (33) : 5118 - +Pfeiler, GeorgHlauschek, DominikMayer, Erica L.Deutschmann, ChristineKacerovsky-Strobl, StephanieMartin, MiguelMeisel, Jane LoweZdenkowski, NicholasLoibl, SibylleBalic, MarijaPark, HaeseongPrat, AleixIsaacs, ClaudineBajetta, EmilioBalko, Justin M.Bellet-Ezquerra, MerixtellBliss, JudithBurstein, HaroldCardoso, FatimaFohler, HannesFoukakis, TheodorosGelmon, Karen A.Goetz, MatthewHaddad, Tufia C.Iwata, HirojiJassem, JacekLee, Soo-ChinLinderholm, BarbroLos, MaartjeMamounas, Eleftherios P.Miller, Kathy D.Morris, Patrick G.Munzone, ElisabettaGal-Yam, Einav NiliRing, AlistairShepherd, LoisSinger, ChristianThomssen, ChristophTseng, Ling-MingValagussa, PinucciaWiner, Eric P.Wolff, Antonio C.Zoppoli, GabrieleMachacek-Link, JanaSchurmans, CelineHuang, XinGauthier, EricFesl, ChristianDueck, Amylou C.DeMichele, Angela
- [9] Barriers to patient adherence with adjuvant endocrine therapyJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Duff, Jennifer MichelleYan, HuiChang, MyronRosenberg, EricDaily, Karen Colleen